Axoft Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $55M

  • Investors
  • 23

Axoft General Information

Description

Developer of an ultrasoft, minimally invasive brain implant technology designed to record neural activity and support diagnosis and treatment of severe neurological conditions. The company offers high-resolution single-neuron brain interfaces capable of accessing cortical and deep brain regions, enabling patients with disorders of consciousness to gain improved prognosis and communication while supporting future neuromodulation therapies.

Contact Information

Website
www.axoft.us
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 148 Sidney Street
  • Cambridge, MA 02139
  • United States
+1 (857)
Primary Industry
Therapeutic Devices
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Nanotechnology, Digital Health, HealthTech, Life Sciences
Corporate Office
  • 148 Sidney Street
  • Cambridge, MA 02139
  • United States
+1 (857)

Axoft Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axoft Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 22-Apr-2026 $55M Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 01-Jan-2026 Completed Clinical Trials - Phase 1
6. Grant 29-Oct-2025 Completed Clinical Trials - Phase 1
5. Accelerator/Incubator 01-Jul-2023 Completed Product Development
4. Accelerator/Incubator 01-May-2023 Completed Product Development
3. Seed Round 20-Oct-2022 Completed Product Development
2. Accelerator/Incubator 01-Sep-2021 Completed Product Development
1. Accelerator/Incubator Completed Startup
To view Axoft’s complete valuation and funding history, request access »

Axoft Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-2
Seed-1 863,196 $0.000100 $0.9 $0.9 1x $0.9 5.46%
Seed 1,853,989 $0.000100 $4.32 $4.32 1x $4.32 11.72%
To view Axoft’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Axoft Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ultrasoft, minimally invasive brain implant technology designed to record neural activity and support di
Therapeutic Devices
Cambridge, MA
40 As of 2026

Geneva, Switzerland
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axoft Competitors (9)

One of Axoft’s 9 competitors is Neurosoft Bioelectronics, a Venture Capital-Backed company based in Geneva, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurosoft Bioelectronics Venture Capital-Backed Geneva, Switzerland
Precision Neuroscience Venture Capital-Backed New York, NY
PathMaker Neurosystems Venture Capital-Backed Boston, MA
Synchron Venture Capital-Backed New York, NY
Neuralink Venture Capital-Backed Fremont, CA
You’re viewing 5 of 9 competitors. Get the full list »

Axoft Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

Axoft Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026217786-A1 Systems and methods for implanting and explanting implantable devices Pending 10-Apr-2025
WO-2026183160-A1 Protium-deficient cross-linked polymer networks and methods of use for enhancing imaging of foreign objects Pending 26-Feb-2025
WO-2026096357-A1 Systems and methods of training and using a neural decoder Pending 28-Oct-2024
EP-4747311-A1 Perfluoropolyether copolymers for biomedical applications Pending 20-Jul-2023
US-20250026885-A1 Perfluoropolyether copolymers for biomedical applications Pending 20-Jul-2023 C08J3/24
To view Axoft’s complete patent history, request access »

Axoft Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axoft Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charoen Pokphand Group Corporation Minority
Gaorong Ventures Venture Capital Minority
Hillhouse Investment Group PE/Buyout Minority
LongRiver Investments Venture Capital Minority
Stanford President's Venture Fund Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Axoft FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process